This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lovelace Biomedical Research Institute. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Michael Burke - Innovator in Cancer Treatment
Introduction
Michael Burke is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on developing pharmaceutical compositions that can improve patient outcomes.
Latest Patents
Michael Burke holds a patent for an "Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer." This invention provides a dry powder pharmaceutical composition suitable for aerosol dispersion for inhaled administration to cancer patients. The composition includes a cytidine analogue along with pharmaceutically acceptable excipients, making it effective for treating patients in need.
Career Highlights
Burke's career is marked by his dedication to advancing medical treatments. He has been instrumental in developing methods that enhance the delivery of cancer therapies. His work is recognized for its potential to change the landscape of cancer treatment.
Collaborations
Michael collaborates with esteemed colleagues such as Steven A. Belinsky and Philip J. Kuehl. These partnerships have fostered a productive research environment, leading to innovative solutions in the medical field.
Conclusion
Michael Burke's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the medical research community. His work continues to inspire advancements in pharmaceutical compositions aimed at improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile